Furthermore, they can drive the activation of other immune cell populations, such as DC, and are able to target tumor-associated macrophages, myeloid-derived suppressor cells and IL-10-secreting neutrophils which generally characterize the immunosuppressive tumor microenvironment, as well as cancer stem cells (9, 10). The gene discussed is IL10; the disease is cancer.